Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IgG antibodies against SARS-CoV-2 decay but persist 4 months after vaccination in a cohort of healthcare workers
Giulia Brisotto, Elena Muraro, Marcella Montico, et al.
Clinica Chimica Acta (2021) Vol. 523, pp. 476-482
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Characterization of the significant decline in humoral immune response six months post‐SARS‐CoV‐2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 2939-2961
Open Access | Times Cited: 117
Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review
Maria da Conceição Rodrigues Fernandes, Germana Silva Vasconcelos, Amanda Campelo Lima de Melo, et al.
Molecular Immunology (2023) Vol. 156, pp. 148-155
Open Access | Times Cited: 34
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine
Bruna Lo Sasso, Luisa Agnello, Rosaria Vincenza Giglio, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 38
Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2
Fubin Pei, Shasha Feng, Wei Hu, et al.
Talanta (2022) Vol. 253, pp. 124051-124051
Open Access | Times Cited: 22
Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
Chiara Orlandi, Giuseppe Stefanetti, Simone Barocci, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1162-1162
Open Access | Times Cited: 11
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population
Kazi Istiaque Sanin, Mansura Khanam, Azizur Rahman Sharaque, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 67-67
Open Access
Post COVID-19 vaccination binding and neutralizing antibody with or without previous infection: An 18-month longitudinal study in Indonesia
Tonang Dwi Ardyanto, Khariri Khariri, Telly Purnamasari Agus, et al.
Narra J (2024) Vol. 4, Iss. 2, pp. e1071-e1071
Open Access | Times Cited: 3
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study
Nejla Stambouli, Khadija Bahrini, Chihebeddine Romdhani, et al.
Journal of Immunological Methods (2024) Vol. 528, pp. 113665-113665
Open Access | Times Cited: 2
Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review
Kin Israel Notarte, Israel Guerrero‐Arguero, Jacqueline Veronica Velasco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16
Factors Associated With the Decay of Anti-SARS-CoV-2 S1 IgG Antibodies Among Recipients of an Adenoviral Vector-Based AZD1222 and a Whole-Virion Inactivated BBV152 Vaccine
Sivaprakasam T. Selvavinayagam, Yean K. Yong, Hong Yien Tan, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 10
Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
Chiara Pellicano, Roberta Campagna, Alessandra Oliva, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 9, pp. 2755-2763
Open Access | Times Cited: 9
Immunochromatographic enhancement strategy for SARS-CoV-2 detection based on nanotechnology
Qingwen Sun, Qihong Ning, Tangan Li, et al.
Nanoscale (2023) Vol. 15, Iss. 37, pp. 15092-15107
Closed Access | Times Cited: 4
The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines
Monika Skorupa, Joanna Szczepanek, Agnieszka Goroncy, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 506-506
Open Access | Times Cited: 7
Serological Response and Relationship with Gender-Sensitive Variables among Healthcare Workers after SARS-CoV-2 Vaccination
Roberto Cangemi, Manuela Di Franco, Antonio Angeloni, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 994-994
Open Access | Times Cited: 7
Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors
A. Gaviria, Rafael Tamayo‐Trujillo, Elius Paz‐Cruz, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Technology-assisted adaptive recruitment strategy for a large nation-wide COVID-19 vaccine immunogenicity study in Brunei
Chin Yee Shim, Si Yee Chan, Yuan Wei, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 6
Kinetics of Humoral Immunity against SARS-CoV-2 in Healthcare Workers after the Third Dose of BNT162b2 mRNA Vaccine
Tiziana Grassi, Giambattista Lobreglio, Alessandra Panìco, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1948-1948
Open Access | Times Cited: 6
Antibodies to SARS-CoV2 induced by vaccination and infection correlate with protection against the infection
Noelia Flor, María I. Rodríguez García, Ana Molineri, et al.
Vaccine (2023) Vol. 41, Iss. 48, pp. 7206-7211
Closed Access | Times Cited: 3
Humoral and T-cell mediated response after administration of mRNA vaccine BNT162b2 in frail populations
Roberta Campagna, Laura Mazzuti, Giuliana Guerrizio, et al.
Vaccine X (2022) Vol. 12, pp. 100246-100246
Open Access | Times Cited: 4
A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines
Yuting Tan, Shi Zou, Fangzhao Ming, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Integration of Cellular and Humoral Immune Responses as an Immunomonitoring Tool for SARS-CoV-2 Vaccination in Healthy and Fragile Subjects
Giulia Brisotto, Marcella Montico, Matteo Turetta, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1276-1276
Open Access | Times Cited: 2
Eleven-month SARS-CoV-2 binding antibody decay, and associated factors, among mRNA vaccinees: implications for booster vaccination
Michael Asamoah-Boaheng, Brian Grunau, Scott Haig, et al.
Access Microbiology (2023) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Anticuerpos postvacunales frente a SARS-CoV-2 en una cohorte de trabajadores de un hospital general
Susana Sabater Vidal, María Dolores Tirado-Balaguer, Raquel Soria-Martín, et al.
Archivos de Prevención de Riesgos Laborales (2022) Vol. 25, Iss. 4, pp. 358-378
Open Access | Times Cited: 3
Evolution of Acquired Humoral Immunity after Full Vaccination against SARS-CoV-2. IgG Levels in Healthcare Workers at 6 and 9 Months
María Victoria Delicado Useros, Esther Navarro-Rodenas, Indalecio Miguel Sánchez Onrubia, et al.
World Journal of Vaccines (2023) Vol. 13, Iss. 02, pp. 13-32
Open Access | Times Cited: 1
Immune Response after Anti-SARS-CoV-2 mRNA Vaccination in Relation to Cellular Immunity, Vitamin D and Comorbidities in Hemodialysis Patients
Eglė Dalinkevičienė, Brigita Gradauskienė, Sandra Sakalauskaitė, et al.
Microorganisms (2024) Vol. 12, Iss. 5, pp. 861-861
Open Access
Page 1 - Next Page

Scroll to top